CGH
MDCO

Crossmark Global Holdings’s Medicines Co MDCO Stock Holding History

Crossmark Global Holdings’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,420
Closed -$630K – 1403
2019
Q4 		$630K Buy
7,420
+480
+7% +$32K 0.02% 704
2019
Q3 		$347K Sell
6,940
-160
-2% -$6.38K 0.01% 969
2019
Q2 		$259K Buy
+7,100
New +$232K 0.01% 1161
2018
Q4 		– Sell
-11,059
Closed -$331K – 1607
2018
Q3 		$331K Buy
11,059
+180
+2% +$6.78K 0.01% 1249
2018
Q2 		$399K Hold
10,879
– – 0.01% 1110
2018
Q1 		$358K Sell
10,879
-3,269
-23% -$102K 0.01% 1144
2017
Q4 		$387K Sell
14,148
-281
-2% -$8.65K 0.01% 1190
2017
Q3 		$534K Buy
+14,429
New +$532K 0.01% 918
2016
Q3 		$534K Buy
+14,429
New +$544K 0.01% 918

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Crossmark Global Holdings's MDCO Position: Q1 2020 in Review

Crossmark Global Holdings sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 7,420 shares — an estimated $630K sold.

Crossmark Global Holdings first reported a position in MDCO in Q3 2016 and held it in 9 quarters. The position peaked at $630K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Crossmark Global Holdings reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 7,420 Medicines Co shares in Q1 2020, an estimated $630K.
  • Crossmark Global Holdings first reported a position in Medicines Co in Q3 2016 and held it in 9 quarters.
  • Crossmark Global Holdings's Medicines Co position peaked at $630K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Crossmark Global Holdings's 13F filing for Q1 2020, filed 28 Apr 2020.